After making a 40% gain in the past week, Asep Medical Holdings $ASEP/$ASEP.C is looking more and more appealing every day.
Prices have definitely fallen considerably since IPO, but if $ASEP can make it back up to where it started, we’ll be looking at a gain of 130%.
$ASEP currently has two products in production that offer them a huge opportunity to seize a sizeable share of the global antibiotics and infection diagnostics market. Its diagnostic technology offers 5 times faster diagnosis of sepsis infections, and its therapeutic treatment offers a solution to previously antibiotic-resistant biofilm infections via its patented peptide technology.
Products are currently in pre-clinical development but are expected to progress quickly. With the market for sepsis treatments alone currently valued at $1 billion and exected to grow at a CAGR of 8.5%, there is some huge opportunity for groth for $ASEP.
I’m staying bullish on $ASEP and am keeping alerts set for any and all news about the development of their products.
$ASEP is currently trading at $.7 and is valued at an MCAP of $39.39 million.
https://asepmedical.com/investors/